EP Edge™ Journal Watch: AVANT GUARD Trial, PFA as First-Line Therapy for Persistent AF: Half the Story

Episode 25

0:00-24:08

In this special HRS 2026 edition of EP Edge™ Journal Watch, Dr. Niraj Sharma takes a deep, clinically focused look at the AVANT GUARD trial, published in The New England Journal of Medicine, evaluating pulsed field ablation as initial therapy for treatment-naïve persistent atrial fibrillation.AVANT GUARD delivered the headline many expected: first-line PFA reduced atrial arrhythmia recurrence and AF burden compared with antiarrhythmic drug therapy, with 12-month freedom from atrial arrhythmia of 56% versus 30%. But the story underneath is more complex.This episode examines why AVANT GUARD may influence future AF guidelines while also requiring car...

Publisher

EP Edge Journal Watch: Cardiac Electrophysiology Research

Link

share.transistor.fm/s/97a3101d

Published

May 4, 2026

Duration

24 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Niraj Sharma MD FACC FHRS: Cardiac Electrophysiology & Cardiology

EE

EP Edge Journal Watch: Cardiac Electrophysiology Research

@epedgejournalwatchcardiacele

#avantguardtrial #linetherapy #persistentaf #lifesciences #medicine

The Nile